LIXT — Lixte Biotechnology Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- $5.33m
- $5.42m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.44 | -3.26 | -6.73 | -6.31 | -5.09 |
Non-Cash Items | 0.749 | 1.25 | 2.6 | 1.55 | 0.773 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.018 | -0.118 | -0.013 | 0.155 | 0.021 |
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -1.67 | -2.13 | -4.14 | -4.61 | -4.29 |
Financing Cash Flow Items | — | — | -0.01 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 0 | 4.6 | 3.9 | 5.14 | 3.14 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.67 | 2.47 | -0.246 | 0.53 | -1.15 |